Epilepsy and Seizure News
Neurofeedback News
Camelback Recovery Launches Neurofeedback Therapy at Its Phoenix Treatment Center -
Camelback Recovery has launched neurofeedback therapy at its Phoenix treatment center, expanding the care options available within its mental health and addiction programs. Phoenix, Arizona--(Newsfile ...
How virtual reality is changing brain-training technology -
Integrating virtual reality into brain-training therapies can make the experience more enjoyable and engaging for users. A recent review published in the journal Applied Psychophysiology and ...
What Is Neurofeedback Therapy? -
Neurofeedback is a noninvasive form of therapy that trains the brain to improve various neurological issues, including chronic pain, ADHD, anxiety, depression and PTSD. Using EEG to monitor real-time ...
Muse Treatment Publishes New Neurofeedback Resource Following 2026 Addiction Research and Changing Overdose Trends -
LOS ANGELES, CA - September 14, 2026 - PRESSADVANTAGE - Muse Treatment has published a new educational resource ...
Novel neurofeedback technique enhances awareness of mind-wandering -
Everyone knows the feeling. You are trying to concentrate on driving or studying, or paying attention in a boring meeting, but suddenly, you realize that you are thinking about something irrelevant to ...
Medical News Today
PubMed
High frequency stimulation in thalamic reticular nucleus blocks the effect of pentylenetetrazole -
High-frequency stimulation (HFS) is an alternative and promising treatment for intractable epilepsy; however, the optimal targets remain unknown. The thalamic reticular nucleus (TRN) occupies a key position in the modulation of cortico-thalamic and thalamo-cortical pathways. HFS-TRN retarded the generalization of PTZ-induced seizures. To explore the mechanism underlying HFS-TRN, we recorded TRN...
Discovery of H-10 as a potent and safe GABAA receptor positive allosteric modulator: A novel benzothiazine-triazole lead compound with broad-spectrum anticonvulsant activity -
Epilepsy is a severe chronic neurological disorder predominantly caused by aberrant neuronal firing within the central nervous system. Herein, we report the design, synthesis, and biological evaluation of a series of 6-alkoxy-2-(4H-1,2,4-triazol-4-yl)-4H-benzo[d][1,3]thiazine derivatives based on a novel benzothiazine-triazole scaffold. Whole-cell patch-clamp recordings were performed on HEK-29...
Ras-MAPK somatic variants in mesial temporal lobe epilepsy -
Mesial temporal lobe epilepsy is the most common focal epilepsy in adults and has historically been attributed to acquired hippocampal injury caused by precipitating insults such as prolonged febrile seizures and head trauma. However, recent studies have identified somatic variants activating Ras-MAPK signaling in more than 40% of surgically resected mesial temporal lobe epilepsy (MTLE) hippoca...
Epilepsy with myoclonic-atonic seizures: a comprehensive review with emphasis on current and emerging pharmacotherapies -
INTRODUCTION: Epilepsy with myoclonic-atonic seizures (EMAtS), historically termed Doose syndrome, is a developmental and epileptic encephalopathy characterized by the usually abrupt onset of multiple generalized seizure types, including myoclonic-atonic seizures, in early childhood. Advances in genetic diagnostics, antiseizure treatments, and precision therapies have reshaped understanding and...
Early treatment prevents neuronal loss in experimental status epilepticus: A magnetic resonance spectroscopic imaging study -
OBJECTIVE: In status epilepticus there are concerns that the prolonged high-intensity electrographic seizure activity causes neuronal death and poorer outcomes. In animal models of status epilepticus, early treatment that stops the seizures prevents the later development of epilepsy. We wished to determine if that same treatment prevents the neuronal damage that is associated with the prolonged...
Ictal laughter induced by repetitive transcranial magnetic stimulation in stroke patients: a case series -
CONCLUSIONS: To our knowledge, this is the first report of rTMS-induced ictal laughter in stroke patients. These observations expand the spectrum of rTMS-associated adverse effects, challenge the assumption that low-frequency protocols are uniformly safe in the post-stroke population, and underscore the need for clinical vigilance in patients with structural brain lesions.
Science Daily